Daiwa Securities Group’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-300
Closed -$1K 1344
2025
Q1
$1K Buy
+300
New +$953 ﹤0.01% 1259
2023
Q4
Sell
-152
Closed -$1K 1393
2023
Q3
$1K Hold
152
﹤0.01% 1278
2023
Q2
$2K Hold
152
﹤0.01% 1249
2023
Q1
$2K Hold
152
﹤0.01% 1229
2022
Q4
$1K Buy
+152
New +$2.14K ﹤0.01% 1293

Other funds holding TSVT

Daiwa Securities Group's TSVT Position: Q2 2025 in Review

Daiwa Securities Group sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 300 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in TSVT in Q4 2022 and held it in 5 quarters. The position peaked at $2K in Q2 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Daiwa Securities Group reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Daiwa Securities Group sold 300 2seventy bio shares in Q2 2025, an estimated $1K.
  • Daiwa Securities Group first reported a position in 2seventy bio in Q4 2022 and held it in 5 quarters.
  • Daiwa Securities Group's 2seventy bio position peaked at $2K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Daiwa Securities Group's 13F filing for Q2 2025, filed 14 Aug 2025.